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Natural killer (NK) cells have been proposed as a  first level of defense against 
the  initiation  and  spread  of tumors  in  vivo (1).  Recent  studies  with  syngeneic 
mice  have  directly  correlated  levels  of  NK  activity  with  resistance  to  tumor 
growth  (reviewed in 2).  However,  most of these  investigations have  used long- 
passaged transplantable tumor cell lines rather than newly transformed cells. We 
had predicted  that,  if NK ~Cells played a  true surveillance role, host cells should 
become susceptible  to  NK-mediated  cytotoxicity during  transformation  to  the 
malignant  phenotype.  The  present  study  demonstrates  that  NK-resistant  rat 
fibroblasts transformed with the v-Ki-ras oncogene become anchorage independ- 
ent,  grow  as  tumors  in  nude  mice,  and  acquire  NK  sensitivity.  These  results 
indicate  that  NK cells can recognize and  kill  newly transformed  cells and  that 
conceivably they play an early role in host surveillance against neoplasia. 
Materials and Methods 
Cells.  Rat-l, a cell line derived from Fisher rat F2408 fibroblasts (3), was transfected 
and injected into NIH-II nu/nu  mice (2  ×  106 cells per mouse, subcutaneously).  Large 
growing tumors were explanted in vitro after 3 wk and reestablished as cell lines. Injection 
of nontransfected rat-1 cells resulted in a barely palpable, benign nodule, which was also 
established as a cell line and used as a control in most experiments. The NK clones LH 
49 (cytolytic) and L250-A9 (less cytolytic) were gifts of Dr. C. Brooks (4). 
Transfection Protocol.  Rat-1  was transfected with the entire 7.0 kilobase (kb) v-Ki-ras 
oncogene ligated into the  Eco  RI site of pBR322  (5).  The transfection procedure has 
been previously described (6). Transfected cells were selected by colony formation in  1% 
methyl cellulose at 3-6 wk (7). 
Cytotoxicity Assays.  Target cells  labeled with 51Cr were analyzed in  6-h assays with a 
variety of effectors (see Table II) as previously described (1). 
Southern Blot Analysis of Transfectants.  DNA (15 #g) was digested with Eco RI, blotted 
(8),  and  hybridized to a  0.6  kb Kpn I  fragment of v-Ki-ras corresponding to the  long- 
terminal repeat sequence of the oncogene. After washing under high stringency, autora- 
diograms were exposed overnight. 
Results and Discussion 
Cytotoxicity assays performed on transformed and untransformed  lines dem- 
onstrated  that  transfection  of  the  v-Ki-ras  oncogene  enhanced  NK-mediated 
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killing. As shown in Fig.  1, the transformed cells were much more sensitive (P < 
0.01)  than  the  rat-1  parent  to  lysis  by  nylon  wool-passed  spleen  ceils  from 
poly(I)C-boosted CBA/J  mice.  This  difference  was >20-fold  in  terms  of lytic 
units calculated at 10% lysis. Since the parent cells are essentially resistant to NK 
lysis, they required >106 lymphocytes to even approach this level of killing. The 
difference was even  more  striking  when  the  LH49  NK  clone  was used as an 
effector. 
Transformed  cells  injected  subcutaneously into  nude  mice  grew as tumors, 
and  were subsequently reestablished  in  culture.  Cytotoxicity assays performed 
on tumor cells passaged through  nude mice consistently showed that they were 
also highly NK sensitive.  As summarized  in  Table  I, data from seven replicate 
experiments demonstrate that the newly transformed and tumor-derived Ki-ras- 
A cells are 26-58-fold more NK sensitive than rat-l, and 6-12-fold less sensitive 
than  the  standard  NK-sensitive tumor,  YAC  1.2.  Both the parental  rat-1  cells 
and  a  line  established  from  a  benign,  barely  palpable  nodule  at the  site  of 
injection of untransfected  rat-1  cells were NK resistant  (<1  lytic unit per  106). 
Two  additional,  independently  derived  rat-1  transformants  (Ki-ras-B  and  -C) 
were also converted to NK sensitivity after transfection  with v-Ki-ras (Table I) 
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FIGURE  1.  Nontransformed  rat-I  cells  ((3),  cells  from  the  v-Ki-ras-transformed  cell  lines 
grown in vitro (I-q) or in vivo (A), and YAC 1.2 lymphoma cells (@) were labeled with 51Cr and 
tested in a  6-h cytotoxicity assay against nylon wool-passed spleen cells from six CBA/J mice 
injected 24  h  previously with  100 #g (1  U) of polyinosinic-polycytidylic acid [poly(1)C] per 
mouse. Values represent the mean percent lysis in triplicate wells.  Values for the percent lysis 
of K-ras A transfectants and K-ras A tumor-derived cells were compared with the parent rat- 
1  line using Student's t  test.  Lysis  values  for  both  transformed cell  lines were  statistically 
different from rat-1  for all effector/target ratios >12:1, with P  <  0.01.  Standard errors for 
replicate experiments are indicated in Table I. This experiment was repeated seven times with 
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TABLE  I 




Target cells  perilnents  LU/106  Pecent lysis 
(100:1 E/T) 
YAC 1.2  7  332 +  122  42 +- 2 
Rat-I  5  <0,5  --. 0.2  3 +-- 2 
Nodule  6  1 --. 0.9  7  -+ 2 
K-ras A  7  26 +_ 12  23 +- 10 
K-ras A tumor  7  58 _+ 20  32 +- 6 
K-rasB  2  6+  1  20-+4 
K-ras B tumor  1  10  17 
K-ras C  2  8 _+ 2  18 +  2 
K-ras C tumor  4  11 +_ 3  21 +  5 
Fresh spleen cells from CBA/J mice boosted 24 h previously with 100 ttg of poly (I)C 
were titrated in serial dilutions at effector/target (E/T) ratios of between 200:1 and 
3:1. Lyric milts (LU) were calculated from titration curves; and  1 LU is defined as 
the  number of lymphocytes required to lyse  10% of 51Cr-labeled targets in a  6-h 
assay; the values shown represent LU per  106 effector lymphocytes. Percent lysis is 
indicated at the  100:1 effector/target ratio.  Data represent the mean and standard 
error of replicate experiments. 
TABLE  II 
Characterization  of the NK Effector Cell 
Strain 
Cytolysis 
Assay  Poly  Spleen frac-  Treatment  YAC  Ki-ras A tumor 
time  (1)C  fionation 




6  -  None 
6  +J  None 
10  -  Nylon 
10  +  Nylon 
10  +  Nylon 
10  +  Nylon 
10  +  Nylon 
10  +  Nylon 
1)BA/2  4  +  Nylon 
Wistar-Firth  4  +  Nylon 
1-at 
C57BL/6  6  -  -- 
6  ~  -- 
%  % 
None  33  ND  11  8 
None  42  ND  26  50 
wool  ~  Anti-Lyt-l.l, 2.1 *  80  160  55  45 
wool  Anti-Lyt-l.1, 2.1  82  250  52  50 
wool  Anti-Lyt-l.l, 2.1, asialo  63  125  28  25 
GM~** 
wool  Anti-Lyt-1.1, 2,1  74  100  35  41 
wool  Anti-Lyb1.1, 2.1, NK-1,2**  44  34  1  <1 
wool  Anti-Lyt-l.l, 2.1, NK-2A  47  31  2  <1 
wool  N one  17  18  12  10 
wool  None  17  25  33  1 I5 
NK clone LH 49  21  500  41  1000 
NK clone L250-A9  7  62  9  110 
* Percent cytolysis of StCr-labeled target cells at a  100:1 effector/target ratio. 
* A  lyric unit (LU) was defined as the nmnber of lymphocytes required to lyse 10% of targets, The value shown 
represent LU per  106 effector lymphocytes. 
Mice were boosted intraperitoneally with 100 ug (1  U) of poly(1)C 24 h  before assay. 
Spleen cells were pooled from 4 to  18 animals per group and passed over nylon wool columns. 
q 107 Spleen cells/ml were treated 1 h  at 4 °C with a  1:20 dilution of monocolonal anti-Lyt-1.1 mixed with 1:20 
anfi-Lyt-2.1  (Cedarlane  Laboratories), followed by washing and a  1-h  incubation at  37°C  with  1:10  rabbit 
complement preabsorbed with mouse tissues. 
** After anti-Lyt-1.1, 2.1 and complement treatment, spleen cells were treated with 1:100 rabbit anti-asia]o GMI 
sera or 1:80 mouse anti-NK-1.2 or -2.1 sera followed by 1:10 rabbit complement. 
These experiments were repeated 3 times with similar results. 
whereas cells transfected with v-fes remained NK resistant (data not shown). 
The characteristics of effector cells that caused cytolysis of transfected targets 
are  summarized  in  Table  II.  Although  normal,  unfractionated  CBA/J  mouse 
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in  a  sixfold  enhancement  of the  effect.  The  poly(I)C  augmentation  was  less 
apparent when using nylon wool column-passed spleen cells depleted of Lyt-1 + 
and  Lyt-2  + effectors. In addition  to being  Lyt-l-,2- phenotype, the antitumor 
effector cells  were partially  depleted  by treatment  with  anti-asialo  GM1,  and 
totally eliminated  by treatment  with anti-NK-1.2  or NK-2.1.  Experiments  with 
cloned NK cell lines of varying cytolytic potential, kindly provided by C. Brooks 
(4), demonstrated that the clones lysed YAC-1.2 and the transfected tumor line 
equally,  but  had  negligible  effects on  the  rat-1  parent.  The  phenotype of the 
effector cell that mediates cytolysis of rat-I  transformants is Lyt-l-,2-, NK-1.2 +, 
NK-2.1 +, asialo GM1 positive, nylon wool nonadherent,  and poly(I)C boostable. 
Therefore, the effect is most likely mediated by NK cells. 
The  nature  of the  presumptive  target  structures  on  the  transformants  was 
investigated  using  cold-target  competition  studies  to ascertain  if determinants 
were  different  from  those  expressed  on  YAC  1.2.  As  shown  in  Table  III, 
unlabeled Ki-ras A  tumor cells competed with NK cells for lysis of 51Cr-labeled 
YAC. The degree of inhibition was comparable to that observed between labeled 
and unlabeled YAC. Similar results were obtained in the reciprocal experiment 
in  which  the  Ki-ras  A  tumor  cells  were  labeled  and  killing  was  reduced  by 
competition  with either  unlabeled  Ki-ras-A  tumor cells or unlabeled YAC  1.2. 
Nontransformed cells did not compete in either system. 
Transfection  was verified by Southern  blot analysis of genomic DNA hybrid- 
ized  to a  0.6  kb segment  from  the  original  v-Ki-ras-transfected  gene  (Fig.  2). 
This  fragment,  which  corresponds to the  viral  long-terminal  repeats (LTR) in 
the  oncogene,  hybridized  strongly to  DNA  from  the  transfected  cells but not 
control lines, under the conditions descibed above. 
These results suggest that transformation  of NK-resistant fibroblast lines with 
specific oncogenes such as v-Ki-ras converts the cells to an NK-sensitive, anchor- 
age-independent,  malignant phenotype. Tumor progression is likely related to a 
loss of NK sensitivity since studies of rat  fibroblast cell  lines transformed  with 
adenovirus 2 have revealed an inverse correlation between NK susceptibility and 
TABLE  IiI 
Competitive Inhibition by YAC and Ki-ras Transfectants 
Competitors (× 10  s) 
Labeled target  Unlabeled competitor  required for 50% 
inhibition of lysis 
YAC 1.2  YAC 1.2  8 
K-ras A tumor  4 
Rat- 1  >64 
Nodule  >64 
K-ras A tunlor  YAC  1.2  4 
K-ras A tumor  4 
Rat- 1  >64 
Nodule  >64 
YAC  1.2 and nude mouse-passaged, v-Ki-ras A-transfected, rat-1  tumor cells were 
labeled with ~Cr and tested in a  6-h cytotoxlcity assay against nylon wool-passed 
spleen cells from  six CBA/J  mice injected 24  h  previously with  100  /~g (1  U)  of 
poly(l)C acid. Varying numbers of unlabeled target cells were added to a constant 
number of 5~Cr-labeled targets (2  ×  10S/well) at an effector/target ratio of 100:1. 
The mean percent lysis values from triplicate wells were plotted and the number of 
competitors causing 50% inhibition of cytolysis was calculated by interpolation. This 
experiment was repeated five times with similar results. 1736  JOHNSON  ET  AL.  BRIEF  DEFINITIVE REPORT 
FIGURE 2.  Southern blot of v-Ki-ras A transfectants.  DNA was extracted from transfected 
and untransfected cell lines and equal amounts were digested  with Eco RI, electrophoresed 
on an agarose gel,  and transferred  to Gene Screen  Plus by Southern  blotting.  Blots were 
probed  with  a  0.6  kb  fragment  of the  transfected  gene  and  autoradiographed.  Tracks 
correspond to equal amounts of DNA from (A) rat-I ; (B) benign nodule at the site of injection 
of rat-1 into nude mice; (C) v-Ki-ras A transfectants;  (D) tumor from nude mice injected  with 
v-Ki-ras A transfectants.  Size markers in kilobasepairs are shown on the left. 
tumorigenesis  in  vivo  (9,  10).  In  a  similar  fashion,  the  extended  growth  and 
selection of methylcholanthrene-treated  fibroblasts in vivo resulted  in the emer- 
gence  of  NK-resistant  variants  (11).  More  extensive  studies  are  currently  in 
progress  in  our  system  to  correlate  the  level  of oncogene  expression  with  the 
degree of malignancy and relative  NK sensitivity. 
Summary 
Transfection  of the  v-Ki-ras  oncogene  into  rat-1  fibroblasts  resulted  in  the 
establishment  of cell  lines  that  were transformed,  tumorigenic,  and  sensitive  to 
lysis by natural  killer  (NK) cells.  Characterization  of effectors indicated  that the 
killing was not related  to Lyt-1 + or Lyt-2  + cells (T cells) but was associated  with 
cells  bearing  NK  markers  (asialo  GM1,  NK-1.2 +,  and  NK-2.1+).  Transfected 
targets were also killed by cloned NK lines.  The transformation determinants  on 
rat-1  transfectants  cross-competed  with  YAC  1.2  lymphoma cells,  suggesting a 
common  target  structure  on  these  two  diverse  cell  types.  The  results  indicate 
that  the  NK surveillance  system can  recognize and  kill  cells  newly transformed 
by a  member  of the ras oncogene family. 
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